Updated Jul 16, 2026
Carter Paul Rutherford has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Carter Paul Rutherford is a corporate director identified in SEC filings as a director of Immatics N.V., a Dutch-listed biopharmaceutical company focused on cancer immunotherapy. The most recent SEC filing dated June 18, 2026 lists him in the director role for Immatics N.V.
| Role | Director |
|---|---|
| Notability | 40/100 |
Carter Paul Rutherford is a corporate director identified in SEC filings as a director of Immatics N.V., a Dutch-listed biopharmaceutical company focused on cancer immunotherapy. The most recent SEC filing dated June 18, 2026 lists him in the director role for Immatics N.V.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Carter Paul Rutherford profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.